Concepedia

Viktor Chirikov

VC

22

Publications

525

Citations

16

H-Index

2012

Active since

Affiliations

University of Maryland, Baltimore(Current)

Pharmerit (United States)

Sanofi (United States)

Bayer (United States)

The Christie Hospital

Viktor Chirikov is an author at University of Maryland, Baltimore specializing in medicine, health economics, and oncology.

ORCID

Top concepts

Publications per year

2012–2023

22

Publications

22

Effect of social networks intervention in type 2 diabetes: a partial randomised study

Fadia T. Shaya, Viktor Chirikov, DeLeonardo Howard et al. · Journal of Epidemiology & Community Health · 2013 · 81 citations

Comparative and Cost Effectiveness of Treatment Modalities for Hepatocellular Carcinoma in SEER-Medicare

Fadia T. Shaya, Ian Michael Breunig, Brian Seal et al. · PharmacoEconomics · 2013 · 45 citations

, , +14

Long-term Assessment of Healthcare Utilization 5 Years After Respiratory Syncytial Virus Infection in US Infants

Eric A. F. Simões, Viktor Chirikov, Marc Botteman et al. · The Journal of Infectious Diseases · 2019 · 41 citations · Full text

Cost-Effectiveness of Alemtuzumab in the Treatment of Relapsing Forms of Multiple Sclerosis in the United States

Viktor Chirikov, Ingrid Ma, Namita Joshi et al. · Value in Health · 2018 · 31 citations · Full text

Development of a Comprehensive Dataset of Hepatitis C Patients and Examination of Disease Epidemiology in the United States, 2013–2016

Viktor Chirikov, Steven E. Marx, Shivaji Manthena et al. · Advances in Therapy · 2018 · 28 citations · Full text

Rows per page

1–5 of 22